Author:
Pardanani A,Finke C,Lasho T L,Al-Kali A,Begna K H,Hanson C A,Tefferi A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference39 articles.
1. Ansell SM, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link B et al. Pretreatment serum cytokines predict early disease relapse and a poor prognosis in diffuse large B-cell lymphoma (DLBCL) patients. Blood (ASH Annual Meeting Abstracts) 2010; 116: 436.
2. Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A . Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol 2011; 29: 1356–1363.
3. Pardanani A, Begna K, Finke C, Lasho T, Tefferi A . Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis. Am J Hematol 2011; 86: 343–345.
4. Olnes MJ, Sloand EM . Targeting immune dysregulation in myelodysplastic syndromes. JAMA 2011; 305: 814–819.
5. 1. Warlick ED, Miller JS . Myelodysplastic syndromes: the role of the immune system in pathogenesis. Leuk Lymphoma 2011
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献